Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 64109

of illegal drug use may be disqualifying 

for employment with DEA. This forms 

seeks, directly from applicants for 

positions with DEA, information 

pertaining to person history of illegal 

drug use. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond/reply: DEA estimates that 

30,000 respondents will take 5 minutes 

to complete the form. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: DEA estimates this collection 

has a public burden of 2,500 hours. 

If additional information is required 

contact: Brenda E. Dyer, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Patrick Henry Building, 

Suite 1600, 601 D Street NW., 

Washington, DC 20530.

Dated: October 28, 2004. 

Brenda E. Dyer, 

Department Clearance Officer, Department of 

Justice.

[FR Doc. 04–24486 Filed 11–2–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comments Requested

ACTION: 60-day notice of information 

collection under review: application for 

permit to export controlled substances—

DEA Form 161. 

The Department of Justice (DOJ), Drug 

Enforcement Administration (DEA), has 

submitted the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection is 

published to obtain comments from the 

public and affected agencies. Comments 

are encouraged and will be accepted for 

‘‘sixty days’’ until January 3, 2005. This 

process is conducted in accordance with 

5 CFR 1320.10. 

If you have comments, especially on 

the estimated public burden or 

associated response time, suggestions, 

or need a copy of the proposed 

information collection instrument with 

instructions or additional information, 

please contact Patricia M. Good, Chief, 

Liaison and Policy Section, Office of 

Diversion Control, Drug Enforcement 

Administration, Washington, DC 20537. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address one or more 

of the following four points:

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agencies 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of information collection:

Extension of a currently approved 

collection. 

(2) Title of the form/collection:

Application for Permit to Export 

Controlled Substances—DEA Form 161. 

(3) Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: Form Number: DEA Form 

161. Office of Diversion Control, Drug 

Enforcement Administration, 

Department of Justice. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Business or other forprofit. Other: None. Abstract: Title 21 

CFR 1312.22 requires persons who 

export controlled substances in 

Schedules I and II to obtain a permit 

from DEA. Information is used to issue 

export permits, exercise control over 

exportation of controlled substances, 

and compile data for submission to 

United Nations to comply with treaty 

requirements. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: DEA estimates that it takes 222 

respondents an average of 30 minutes to 

respond on an as needed basis, 

submitting 2,444 forms annually. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: DEA estimates that the 

annual burden for this collection is 

1,222 hours.

FOR FURTHER INFORMATION CONTACT:

Brenda E. Dyer, Department Clearance 

Officer, United States Department of 

Justice, Justice Management Division, 

Policy and Planning Staff, Patrick Henry 

Building, Suite 1600, 601 D Street NW., 

Washington, DC 20530.

Dated: October 28, 2004. 

Brenda E. Dyer, 

Department Clearance Officer, Department of 

Justice.

[FR Doc. 04–24487 Filed 11–2–04; 8:45 am] 

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comments Requested

ACTION: 60-Day Notice of information 

collection under review: Registrants’

Inventory of Drugs Surrendered—DEA 

Form 41. 

The Department of Justice (DOJ), Drug 

Enforcement Administration (DEA), has 

submitted the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection is 

published to obtain comments from the 

public and affected agencies. Comments 

are encouraged and will be accepted for 

‘‘sixty days’’ until January 3, 2005. This 

process is conducted in accordance with 

5 CFR 1320.10. 

If you have comments, especially on 

the estimated public burden or 

associated response time, suggestions, 

or need a copy of the proposed 

information collection instrument with 

instructions or additional information, 

please contact Patricia M. Good, Chief, 

Liaison and Policy Section, Office of 

Diversion Control, Drug Enforcement 

Administration, Washington, DC 20537. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address one or more 

of the following four points:

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agencies 

estimate of the burden of the 

proposed collection of information,